Aldebaran Capital’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Sell |
993,698
-14,260
| -1% | -$20.2K | 1.39% | 18 |
|
|
2025
Q1 | $1.54M | Sell |
1,007,958
-9,000
| -0.9% | -$13.8K | 1.46% | 19 |
|
|
2024
Q4 | $2.52M | Sell |
1,016,958
-26,194
| -3% | -$65K | 2.4% | 13 |
|
|
2024
Q3 | $1.2M | Buy |
1,043,152
+185,000
| +22% | +$213K | 1.1% | 20 |
|
|
2024
Q2 | $944K | Buy |
+858,152
| New | +$944K | 0.88% | 21 |
|